<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Welcome to sentence similarity viewer</title>
    <form action="/test_similarity_matrix" method="POST">
        <textarea name="sent1" id="sent1" placeholder="Write here your first sentence." style="width: 705px; height: 59px;">
            Dinutuximab is used for treatment of which disease?
        </textarea>
        </br>
        <textarea name="sent2" id="sent2" placeholder="Write here your second sentence." style="width: 705px; height: 59px;">
            As discussed in this perspective on antibodies in late-stage development, the outlook for additional approvals, potentially still in 2014 and certainly in 2015, is excellent as marketing applications for 7 antibody therapeutics (secukinumab, evolocumab, mepolizumab, dinutuximab, nivolumab, blinatumomab, necitumumab) are undergoing a first regulatory review in the EU or US.
        </textarea>
        </br>
        <input type="submit" value="Submit"/>
    </form>
</head>
<body>

</body>
</html>
